OmicsBank secures $2.25M to expand overseas patient data platform for biopharma

OmicsBank announced it has closed a $2.25 million financing round aimed at scaling its platform that aggregates patient health data from overseas sources for use by biopharma companies.

The company says the new capital will enable it to broaden data collection efforts, improve AI‑driven analytics, and support drug discovery programs that rely on diverse real‑world evidence.

Investors view the funding as a vote of confidence in the growing market for health‑tech data services, reflecting broader industry interest in leveraging AI and global patient datasets to accelerate therapeutic development.